Skip to main content
. 2020 Jun 10;61(6):381–395. doi: 10.1016/j.hjc.2020.05.004

Table 3.

Frequency of cardiovascular comorbidities, preexisting cardiovascular disease, and cardiovascular complications in patients who died due to COVID-19

n Median age, years CV comorbidities
Pre existing CVD
CV complications
Current smoker HTN DM CVD Myocardial injury HF Arrhythmia
Guan166 50 N/A N/A 56.0 26.0 16.0 N/A N/A N/A
Yang53 32A 64.6B 0 N/A 21.9 9.4 28.1 N/A N/A
Zhou48 54 69 9.3 48.1 31.5 24.1C 59.3 51.9 N/A
Ruan51 68 67 N/A 42.6 17.6 19.1 N/A N/A N/A
Shi54 57 N/A N/A N/A N/A N/A 73.7 N/A N/A
Guo55 43 N/A N/A N/A N/A N/A 72.1 N/A N/A
Chen56 113 68 6.2 47.8 21.2 14.2 76.6 49.4 N/A
Mehra170 515 55.8B 8.9 25.2 18.8 20.0C
5.6D
6.8E
N/A N/A N/A
Shi117 62 74 N/A 59.7 27.4 33.9C
21.0F
30.6 19.4 N/A

CV: cardiovascular, CVD: cardiovascular disease, DM: diabetes mellitus, HF: heart failure, HTN: hypertension, n: total deceased patients, N/A: not applicable.

A Only critically ill patients with COVID-19 were included in the study, B Mean age, C Coronary artery disease, D Congestive heart failure, E Arrhythmia, F Chronic heart failure.